SCHEMBL17866100

SCHEMBL17866100

CCOC(=O)OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.45
▸ SLC5A1 P13866 5/20 0.44
▸ SLC5A2 P31639 5/20 0.44
▸ CYP2C19 P33261 4/20 0.41
▸ CYP3A4 P08684 2/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ PTGS1 P23219 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ SLC2A1 P11166 1/20 0.38
▸ SOAT1 P35610 1/20 0.38
▸ TLR4 O00206 1/20 0.37
▸ PRKD3 O94806 1/20 0.37
▸ PRKCG P05129 1/20 0.37
▸ PRKCB P05771 1/20 0.37
▸ PRKCA P17252 1/20 0.37
▸ PRKCH P24723 1/20 0.37
▸ PRKCI P41743 1/20 0.37
▸ PRKCE Q02156 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25167911 0.91 SLC2A1 (0.41) SLC5A1SLC5A2PTGS1PTGS2MAPK1
SCHEMBL23619235 0.85 ALDH1A1 (0.43) ALDH1A1SLC5A1SLC5A2CYP2C19CYP3A4
SCHEMBL17866069 0.84 PYGB (0.42) SLC5A1SLC5A2PTGS1PTGS2MAPK1
SCHEMBL25887782 0.82 PRKD3 (0.43) SLC5A1SLC5A2CYP3A4CYP2C9PTGS1
SCHEMBL10031320 0.82 SLC5A1 (0.52) ALDH1A1SLC5A1SLC5A2CYP2C19SOAT1
SCHEMBL2320834 0.81 TLR4 (0.44) PTGS1PTGS2SLC2A1TLR4PRKD3
SCHEMBL16259333 0.81 TLR4 (0.44) PTGS1PTGS2SLC2A1TLR4PRKD3
SCHEMBL9563973 0.80 PTGS1 (0.40) PTGS1PTGS2HSD17B10SLC2A1TLR4
SCHEMBL15963880 0.80 PTGS1 (0.40) PTGS1PTGS2HSD17B10SLC2A1TLR4
SCHEMBL6015980 0.80 PTGS1 (0.40) PTGS1PTGS2HSD17B10SLC2A1TLR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1782828-B1 PROGRESSION INHIBITOR FOR DISEASE ATTRIBUTED TO ABNORMAL ACCUMULATION OF LIVER FAT KISSEI PHARMACEUTICAL (JP) 2016-06-29 — — EP claimed
Send feedback